Applied DNA Sciences (APDN) Tops Q3 EPS by 19c

Go back to Applied DNA Sciences (APDN) Tops Q3 EPS by 19c

Applied DNA Reports Third Quarter Fiscal 2022 Financial Results

August 11, 2022 4:10 PM EDT

- Clinical Testing Services Drive Revenue Growth of 153% Year-Over-Year to $4.3 Million -

- Post-Quarter Close Cash Balance of $16.8 Million Includes Proceeds from Upsized Public Offering and Warrant Exercises -

- Company to Hold Conference Call and Webcast Today, August 11, 2022, at 4:30 PM ET -

STONY BROOK, N.Y.--(BUSINESS... More